Global Global Depression Drugs Market Analysis, Size, Share, Growth, Future Trends, Covid-19 Impact, SWOT Analysis, Competition and Forecasts 2021 to 2028
Published Date: Dec 2021
No. of Pages: 150
Status: Published
Report Code: ARI101003
Global Depression Drugs Market:
Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025. Growing in geriatric population, increase in the knowledge about depression, rising number of generic drug market and declining side effects of drugs are projected to boost the growth of Global Depression Drugs Market.
Scope of Global Depression Drugs Market Reports:
As per WHO, depression is a common mental disorder includes brain that contributes significantly to the global burden of disease. Depression is a serious mood disorder which causes a tenacious feeling of sadness and loss of interest therefore affecting daily routine activities such as sleeping, walking, talking, thinking and eating. Depression is a mental health issue. It is a condition that begins more often in initial stages of adulthood. Also it is more commonly observe in women. Though, anyone at any age may get suffer from depression. Depression affects the brain so drugs that work in the brain called ‘Antidepressant Drugs’. General anti-depressants can decrease symptoms, but there are many other options to reduce the depression. Each drug used to treat depression by balancing certain chemicals in brain known as ‘Neurotransmitters’. Signs and symptoms of depression differ from individual to individual on the basis of risk factors, individual thinking and lifestyle. It includes sadness, irritability, loss of attention in daily routine activities, feelings of pessimism, guilt, social withdrawal, fatigue, insomnia, loss of appetite, headache, cramps, digestive problems, weight loss or gain, restlessness and suicide attempts. Also, alcoholism and drug abuse may be the signs of depression. Likewise there are different types of depression which has distinctive characteristics such as persistent depressive disorder, perinatal depression disorder, psychotic depression, Seasonal affective disorder and bipolar depression. Depression is also classified based on its severity as mild, moderate and severe. An individual with severe depression can have suicidal thoughts and behaviors. According to 2012estimation by the WHO around 3,000 suicides take place per day, resulting in more than a million deaths each year. Depression can be recurring and can be severely debilitating. Patients with mild depression can be treated with medications but in moderate or severe depression cases, the patient needs both medication and professional psychotherapy in the form of counseling.
The Global Depression Drugs Market is segmented on the basis of Drug type, Disease Type, Distribution channel and Geography. On the basis of Drug type Global Depression Drugs Market is divided into Tricyclic Antidepressants, Serotonin-Norepinephrine Inhibitors, Atypical Antipsychotics, Selective Serotonin Reuptake Inhibitors, Benzodiazepines, Tetracyclic Antidepressants, Monoamine Oxidase Inhibitors and Others. On the basis of Disease Type Global Depression Drugs Market is divided into Major Depressive Disorder, Schizophrenia, Bipolar I Disorder and Selective Serotonin Reuptake Inhibitor Induced Disorder and other. On the basis of Distribution channel Global Depression Drugs Market is divided into Hospital pharmacies, Retail pharmacies, online pharmacies, Clinics and Research centers. The regions covered in Global Depression Drugs Market report are North America, Europe, Asia-Pacific and Rest of the World.
Market Dynamics:
Increasing geriatric population globally, growing efficacy and decreasing side effects of anti-depressant drugs are the main factors that drive the Global Depression Drug Market. Also, various government initiatives in increasing awareness on depression, elevating generic drug market, are boosting the Global Depression Drugs Market. People transfer from rural to urban areas for job, education, etc. and their suddenly changing lifestyle is one of the key factors driving the growth of Global Depression Drugs Market. Though, lack of awareness among persons regarding depression& its growing occurrence and threat of expiry of patents would decline the demand for Antidepressant drugs in forecast period. However, non-availability of well-developed healthcare facilities especially in rural and remote areas may decline the growth of the Global Depression Drugs Market. Growing occurrence of anxiety and several other depression disorders would offer some growth opportunities for the Global Depression Drugs Market in coming years. Furthermore, increasing investments in research & developments and market expansion would offer growth opportunities for the Global Depression Drugs Market players.
Regional Analysis:
Geographically, North America accounted for the largest market share of around 37.20% in 2016; due to high patient awareness levels regarding availability of various antidepressant drugs for increasing healthcare expenditure and relatively larger number of Research & Development affecting to drug manufacturing and marketing etc. These factors contribute for significant revenue generation from the region. Europe have the second largest share of the Global Depression Drugs Market in 2017, which can be recognized to the increase in research and development activities on depression drugs in the region. Asia-Pacific is to attain the fastest CAGR during the forecast period, owed to increased demand from developing countries such as China, Japan, and Australia. An initiative by the local government to reach self-sufficiency in the manufacturing of Antidepressant drugs and increasing awareness amongst consumers regarding benefits of Antidepressant drug is also likely to boost the growth of Global Depression Drugs Market in the region.
Depression Drugs Market Key Players:
Otsuka Pharmaceutical Co., Ltd.
Eli Lilly and Company
Pfizer Inc.
AstraZeneca
Allergan USA, Inc.
Novartis AG
GlaxoSmithKline
Takeda Pharmaceutical Company Ltd
Sebela Pharmaceutical Inc.
Johnson & Johnson
Merck & Co.
SK Biopharmaceuticals
Forest Laboratories
Naurex
Actavis
Bristol-Myers Squibb
Intellipharmaceutics
Lundbeck
Allergan
NHU Group
Shionogi
Kanghong Pharma
HUAHAI
Addex Therapeutics
Other
Depression Drugs Market Segmentation:
By Drug type
Tricyclic Antidepressants
Serotonin-Norepinephrine Inhibitors
Atypical Antipsychotics
Selective Serotonin Reuptake Inhibitors
Benzodiazepines
Tetracyclic Antidepressants
Monoamine Oxidase Inhibitors
Other
By Disease Type
Major Depressive Disorder
Schizophrenia
Bipolar I Disorder
Selective Serotonin Reuptake Inhibitor Induced Disorder
Other
By Distribution channel
Hospital pharmacies
Retail pharmacies
Online pharmacies
Clinics
Research centres
Other
By Region
North America - US, Mexico, Chile, Canada
Europe - UK, France, Germany, Italy
Asia Pacific - China, South Korea, Japan, India, Southeast Asia
Latin America - Brazil
Middle East and Africa - GCC, Africa, Rest of Middle East and Africa
TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data Component
2.3.1. Secondary Component
2.3.1.1. Preliminary data mining
2.3.2. Primary Component
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. Major Depressive Disorder Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Depression Drugs Market
Chapter 5. Global Depression Drugs Market Overview, By Drug type, 2015 - 2028(USD Million)
5.1. Global Depression Drugs Market Share, By Drug type, 2015 - 2028 (USD Million)
5.1.1. Tricyclic Antidepressants
5.1.1.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
5.1.2. Serotonin-Norepinephrine Inhibitors
5.1.2.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
5.1.3. Atypical Antipsychotics
5.1.3.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.3.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
5.1.4. Selective Serotonin Reuptake Inhibitors
5.1.4.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.4.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
5.1.5. Benzodiazepines
5.1.5.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.5.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
5.1.6. Tetracyclic Antidepressants
5.1.6.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.6.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
5.1.7. Monoamine Oxidase Inhibitors
5.1.7.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.7.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
5.1.8. Other
5.1.8.1. Market Size and Projections,2015 - 2028 (USD Million)
5.1.8.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
Chapter 6. Global Depression Drugs Market Overview, By Disease Type, 2015 - 2028(USD Million)
6.1. Global Depression Drugs Market Share, By Disease Type, 2015 - 2028 (USD Million)
6.1.1. Major Depressive Disorder
6.1.1.1. Market Size and Projections,2015 - 2028 (USD Million)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
6.1.2. Schizophrenia
6.1.2.1. Market Size and Projections, 2015 - 2028 (USD Million)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
6.1.3. Bipolar I Disorder
6.1.3.1. Market Size and Projections, 2015 - 2028 (USD Million)
6.1.3.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
6.1.4. Selective Serotonin Reuptake Inhibitor Induced Disorder
6.1.4.1. Market Size and Projections, 2015 - 2028 (USD Million)
6.1.4.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
6.1.5. Other
6.1.5.1. Market Size and Projections, 2015 - 2028 (USD Million)
6.1.5.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
Chapter 7. Global Depression Drugs Market Overview, By Distribution channel, 2015 - 2028(USD Million)
7.1. Global Depression Drugs Market Share, By Distribution channel, 2015 - 2028 (USD Million)
7.1.1. Hospital pharmacies
7.1.1.1. Market Size and Projections,2015 - 2028 (USD Million)
7.1.1.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
7.1.2. Retail pharmacies
7.1.2.1. Market Size and Projections, 2015 - 2028 (USD Million)
7.1.2.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
7.1.3. Online pharmacies
7.1.3.1. Market Size and Projections, 2015 - 2028 (USD Million)
7.1.3.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
7.1.4. Clinics
7.1.4.1. Market Size and Projections, 2015 - 2028 (USD Million)
7.1.4.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
7.1.5. Research centres
7.1.5.1. Market Size and Projections, 2015 - 2028 (USD Million)
7.1.5.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
7.1.6. Other
7.1.6.1. Market Size and Projections, 2015 - 2028 (USD Million)
7.1.6.2. Market Size and Projections, by Region, 2015 - 2028 (USD Million)
Chapter 8. Global Depression Drugs Market Overview, By Geography, 2015 - 2028(USD Million)
8.1. Global Depression Drugs Market Share, By Geography, 2015 - 2028(USD Million)
8.1.1. Market Size and projections, by Countries, 2015 - 2028 (USD Million)
8.1.2. Market Share and CAGR Comparison, by Countries, 2020 - 2028 (%)
Chapter 9. North America Depression Drugs Market Overview, By Countries, 2015 - 2028(USD Million)
9.1. North America Depression Drugs Market Overview, 2015 - 2028 (USD Million)
9.1.1. Market Size and projections, 2015 - 2028 (USD Million)
9.1.2. North America Depression Drugs Market Overview, By Drug type, 2015 - 2028 (USD Million)
9.1.3. North America Depression Drugs Market Overview, By Disease Type, 2015 - 2028 (USD Million)
9.1.4. North America Depression Drugs Market Overview, By Distribution channel, 2015 - 2028 (USD Million)
9.1.5. North America Depression Drugs Market Overview, By Countries, 2015 - 2028 (USD Million)
9.1.5.1. U.S. Depression Drugs Market Overview, 2015 - 2028 (USD Million)
9.1.5.1.1. Market Size and projections, 2015 - 2028 (USD Million)
9.1.5.1.2. U.S. Depression Drugs Market Overview, By Drug type, 2015 - 2028 (USD Million)
9.1.5.1.3. U.S. Depression Drugs Market Overview, By Disease Type, 2015 - 2028 (USD Million)
9.1.5.1.4. Other Segment
9.1.5.2. Canada Depression Drugs Market Overview, 2015 - 2028 (USD Million)
9.1.5.2.1. Market Size and projections, 2015 - 2028 (USD Million)
9.1.5.2.2. Canada Depression Drugs Market Overview, By Drug type, 2015 - 2028 (USD Million)
9.1.5.2.3. Canada Depression Drugs Market Overview, By Disease Type, 2015 - 2028 (USD Million)
9.1.5.2.4. Other Segment
9.1.5.3. Mexico Depression Drugs Market Overview, 2015 - 2028 (USD Million)
9.1.5.3.1. Market Size and projections, 2015 - 2028 (USD Million)
9.1.5.3.2. Mexico Depression Drugs Market Overview, By Drug type, 2015 - 2028 (USD Million)
9.1.5.3.3. Mexico Depression Drugs Market Overview, By Disease Type, 2015 - 2028 (USD Million)
9.1.5.3.4. Other Segment
Chapter 10. Europe Depression Drugs Market Overview, By Countries, 2015 - 2028(USD Million)
10.1. Europe Depression Drugs Market Overview, 2015 - 2028 (USD Million)
10.1.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.2. Europe Depression Drugs Market Overview, By Drug type, 2015 - 2028 (USD Million)
10.1.3. Europe Depression Drugs Market Overview, By Disease Type, 2015 - 2028 (USD Million)
10.1.4. Europe Depression Drugs Market Overview, By Distribution channel, 2015 - 2028 (USD Million)
10.1.5. Europe Skin Care Sizes Market Overview, By Countries, 2015 - 2028 (USD Million)
10.1.5.1. Germany
10.1.5.1.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.5.1.2. Germany Depression Drugs Market Overview, By Drug type, 2015 - 2028(USD Million)
10.1.5.1.3. Germany Depression Drugs Market Overview, By Disease Type, 2015 - 2028(USD Million)
10.1.5.1.4. Other Segment
10.1.5.2. France
10.1.5.2.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.5.2.2. France Depression Drugs Market Overview, By Drug type, 2015 - 2028(USD Million)
10.1.5.2.3. France Depression Drugs Market Overview, By Disease Type, 2015 - 2028(USD Million)
10.1.5.2.4. Other Segment
10.1.5.3. UK
10.1.5.3.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.5.3.2. UK Depression Drugs Market Overview, By Drug type, 2015 - 2028(USD Million)
10.1.5.3.3. UK Depression Drugs Market Overview, By Disease Type, 2015 - 2028(USD Million)
10.1.5.3.4. Other Segment
10.1.5.4. Italy
10.1.5.4.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.5.4.2. Italy Depression Drugs Market Overview, By Drug type, 2015 - 2028(USD Million)
10.1.5.4.3. Italy Depression Drugs Market Overview, By Disease Type, 2015 - 2028(USD Million)
10.1.5.4.4. Other Segment
10.1.5.5. Spain
10.1.5.5.1. Market Size and projections, 2015 - 2028 (USD Million)
10.1.5.5.2. Spain Depression Drugs Market Overview, By Drug type, 2015 - 2028(USD Million)
10.1.5.5.3. Spain Depression Drugs Market Overview, By Disease Type, 2015 - 2028(USD Million)
10.1.5.5.4. Other Segment
10.1.5.6. Rest of Europe
10.1.5.6.1. Market Size and projections, 2015 – 2028
10.1.5.6.2. Rest of Europe Depression Drugs Market Overview, By Drug type, 2015 - 2028(USD Million)
10.1.5.6.3. Rest of Europe Depression Drugs Market Overview, By Disease Type, 2015 - 2028(USD Million)
10.1.5.6.4. Other Segment
Chapter 11. Asia Pacific Depression Drugs Market Overview, By Countries, 2015 - 2028 (USD Million)
11.1. Asia Pacific Depression Drugs Market Overview, 2015 - 2028 (USD Million)
11.1.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.2. Asia Pacific Depression Drugs Market Overview, By Drug type, 2015 - 2028 (USD Million)
11.1.3. Asia Pacific Depression Drugs Market Overview, By Disease Type, 2015 - 2028 (USD Million)
11.1.4. Asia Pacific Depression Drugs Market Overview, By Distribution channel, 2015 - 2028 (USD Million)
11.1.5. Asia Pacific Depression Drugs Market Overview, By Countries, 2015 - 2028 (USD Million)
11.1.5.1. India
11.1.5.1.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.5.1.2. India Depression Drugs Market Overview, By Drug type, 2015 - 2028(USD Million)
11.1.5.1.3. India Depression Drugs Market Overview, By Disease Type, 2015 - 2028 (USD Million)
11.1.5.1.4. Other Segment
11.1.5.2. China
11.1.5.2.1. Market Size and projections, 2015 - 2028(USD Million)
11.1.5.2.2. China Depression Drugs Market Overview, By Drug type, 2015 - 2028(USD Million)
11.1.5.2.3. China Depression Drugs Market Overview, By Disease Type, 2015 - 2028 (USD Million)
11.1.5.2.4. Other Segment
11.1.5.3. Japan
11.1.5.3.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.5.3.2. Japan Depression Drugs Market Overview, By Drug type, 2015 - 2028(USD Million)
11.1.5.3.3. Japan Depression Drugs Market Overview, By Disease Type, 2015 - 2028(USD Million)
11.1.5.3.4. Other Segment
11.1.5.4. South Korea
11.1.5.4.1. Market Size and projections, 2015 - 2028(USD Million)
11.1.5.4.2. South Korea Depression Drugs Market Overview, By Drug type, 2015 - 2028(USD Million)
11.1.5.4.3. South Korea Depression Drugs Market Overview, By Disease Type, 2015 - 2028 (USD Million)
11.1.5.4.4. Other Segment
11.1.5.5. Rest of Asia Pacific
11.1.5.5.1. Market Size and projections, 2015 - 2028 (USD Million)
11.1.5.5.2. Rest of Asia Pacific Depression Drugs Market Overview, By Drug type, 2015 - 2028(USD Million)
11.1.5.5.3. Rest of Asia Pacific Depression Drugs Market Overview, By Disease Type, 2015 - 2028 (USD Million)
11.1.5.5.4. Other Segment
Chapter 12. Middle East & Africa Depression Drugs Market Overview, By Countries, 2015 - 2028 (USD Million)
12.1. Middle East & Africa Depression Drugs Market Overview, 2015 - 2028 (USD Million)
12.1.1. Market Size and projections, 2015 - 2028 (USD Million)
12.1.2. Middle East & Africa Depression Drugs Market Overview, By Drug type, 2015 - 2028 (USD Million)
12.1.3. Middle East & Africa Depression Drugs Market Overview, By Disease Type, 2015 - 2028 (USD Million)
12.1.4. Middle East & Africa Depression Drugs Market Overview, By Distribution channel, 2015 - 2028 (USD Million)
12.1.5. Middle East & Africa Depression Drugs Market Overview, By Countries, 2015 - 2028 (USD Million)
12.1.5.1. GCC
12.1.5.1.1. Market Size and projections, 2015 - 2028 (USD Million)
12.1.5.1.2. GCC Depression Drugs Market Overview, By Drug type, 2015 - 2028 (USD Million)
12.1.5.1.3. GCC Depression Drugs Market Overview, By Disease Type, 2015 - 2028 (USD Million)
12.1.5.1.4. Other Segment
12.1.5.2. South Africa
12.1.5.2.1. Market Size and projections, 2015 - 2028 (USD Million)
12.1.5.2.2. South Africa Depression Drugs Market Overview, By Drug type, 2015 - 2028 (USD Million)
12.1.5.2.3. South Africa Depression Drugs Market Overview, By Disease Type, 2015 - 2028 (USD Million)
12.1.5.2.4. Other Segment
12.1.5.3. Rest of Middle East & Africa
12.1.5.3.1. Market Size and projections, 2015 - 2028 (USD Million)
12.1.5.3.2. Rest of Middle East & Africa Depression Drugs Market Overview, By Drug type, 2015 - 2028 (USD Million)
12.1.5.3.3. Rest of Middle East & Africa Depression Drugs Market Overview, By Disease Type, 2015 - 2028 (USD Million)
12.1.5.3.4. Other Segment
Chapter 13. South America Depression Drugs Market Overview, By Countries, 2015 - 2028 (USD Million)
13.1. South America Depression Drugs Market Overview, 2015 - 2028 (USD Million)
13.1.1. Market Size and projections, 2015 - 2028 (USD Million)
13.1.2. South America Depression Drugs Market Overview, By Drug type, 2015 - 2028 (USD Million)
13.1.3. South America Depression Drugs Market Overview, By Disease Type, 2015 - 2028 (USD Million)
13.1.4. South America Depression Drugs Market Overview, By Distribution channel, 2015 - 2028 (USD Million)
13.1.5. South America Depression Drugs Market Overview, By Countries, 2015- 2026 (USD Million)
13.1.6. Brazil
13.1.6.1. Market Size and projections, 2015 - 2028 (USD Million)
13.1.6.2. Brazil Depression Drugs Market Overview, By Drug type, 2015 - 2028 (USD Million)
13.1.6.3. Brazil Depression Drugs Market Overview, By Disease Type, 2015 - 2028 (USD Million)
13.1.6.4. Other Segment
13.1.7. Argentina
13.1.7.1. Market Size and projections, 2015 - 2028 (USD Million)
13.1.7.2. Argentina Depression Drugs Market Overview, By Drug type, 2015 - 2028 (USD Million)
13.1.7.3. Argentina Depression Drugs Market Overview, By Disease Type, 2015 - 2028 (USD Million)
13.1.7.4. Other Segment
13.1.8. Rest of South America
13.1.8.1. Market Size and projections, 2015 – 2028
13.1.8.2. Rest of South America Depression Drugs Market Overview, By Drug type, 2015 - 2028 (USD Million)
13.1.8.3. Rest of South America Depression Drugs Market Overview, By Disease Type, 2015 - 2028 (USD Million)
13.1.8.4. Other Segment
Chapter 14. Competitive Landscape
14.1. Competitive environment, 2021
14.2. Strategic framework
14.2.1. Partnership/agreement
14.2.2. Expansion
14.2.3. Mergers & Acquisitions
14.2.4. New Size development
Chapter 15. Key Vendor Analysis
15.1. Otsuka Pharmaceutical Co., Ltd.
15.1.1. Company overview
15.1.2. Financial performance
15.1.3. Drug type Benchmarking
15.1.4. Recent initiatives
15.1.5. SWOT analysis
15.2. Eli Lilly and Company
15.2.1. Company overview
15.2.2. Financial performance
15.2.3. Drug type Benchmarking
15.2.4. Recent initiatives
15.2.5. SWOT analysis
15.3. Pfizer Inc.
15.3.1. Company overview
15.3.2. Financial performance
15.3.3. Drug type Benchmarking
15.3.4. Recent initiatives
15.4. AstraZeneca
15.5. Stryker Corporation
15.6. Allergan USA, Inc.
15.7. Novartis AG
15.8. Others
Chapter 16. Depression Drugs Market Cost Analysis
16.1. Depression Drugs Market Key Offering Analysis
16.1.1. Key Offering
16.1.2. Price Trend of Key Drug type
16.1.3. Key Suppliers
16.1.4. Labor Cost
Chapter 17. Industrial Chain, Sourcing Strategy and Downstream Buyers
17.1. Depression Drugs Market Industrial Chain Analysis
17.2. Upstream Offering Sourcing
17.3. Raw Material Sources of Depression Drugs Market Major Manufacturers in 2021
17.4. Downstream Buyers
Chapter 18. Marketing Strategy Analysis, Distributors/Traders
18.1. Marketing Channel
18.1.1. Direct Marketing
18.1.2. Indirect Marketing
18.1.3. Marketing Channel Development Trend
18.2. Market Positioning
18.2.1. Pricing Strategy
18.2.2. Brand Strategy
18.2.3. Target Client
18.3. Distributors/Traders List
Chapter 19. Market Effect Factors Analysis
19.1. Drug type Progress/Risk
19.1.1. Substitutes Threat
19.1.2. Drug type Progress in Related Size
19.2. Consumer Needs/Customer Preference Change
19.3. Economic/Political Environmental Change
Chapter 20. Future Outlook of the Market
Disclaimer
List of Tables
1. Impact of Market drivers
2. Impact of Market restraints
3. Global Depression Drugs Market, 2015-2028 (USD Million)
4. Biochemical Sensor requirement, by country, 2015-2028 (USD Million)
5. North America Depression Drugs Market, By Drug type, 2015-2028 (USD Million)
6. North America Depression Drugs Market, By Disease Type, 2015-2028 (USD Million)
7. North America Depression Drugs Market, By Distribution channel, 2015-2028 (USD Million)
8. Europe Depression Drugs Market, By Drug type, 2015-2028 (USD Million)
9. Europe Depression Drugs Market, By Disease Type, 2015-2028 (USD Million)
10. Europe Depression Drugs Market, By Distribution channel, 2015-2028 (USD Million)
11. Asia Pacific Depression Drugs Market, By Drug type, 2015-2028 (USD Million)
12. Asia Pacific Depression Drugs Market, By Disease Type, 2015-2028 (USD Million)
13. Asia Pacific Depression Drugs Market, By Distribution channel, 2015-2028 (USD Million)
14. Middle East & Africa Depression Drugs Market, By Drug type, 2015-2028 (USD Million)
15. Middle East & Africa Depression Drugs Market, By Disease Type, 2015-2028 (USD Million)
16. Middle East & Africa Depression Drugs Market, By Distribution channel, 2015-2028 (USD Million)
17. South America Depression Drugs Market, By Drug type, 2015-2028 (USD Million)
18. South America Depression Drugs Market, By Disease Type, 2015-2028 (USD Million)
19. South America Depression Drugs Market, By Distribution channel, 2015-2028 (USD Million)
20. Global Depression Drugs Market, Company Market Share, 2020 - 2028 (%)
21. Otsuka Pharmaceutical Co., Ltd.: Drug type Benchmarking
22. Otsuka Pharmaceutical Co., Ltd.: Financial Performance
23. Eli Lilly and Company: Drug type Benchmarking
24. Eli Lilly and Company: Financial Performance
25. Pfizer Inc.: Drug type Benchmarking
26. Pfizer Inc.: Financial Performance
27. AstraZeneca: Drug type Benchmarking
28. AstraZeneca: Financial Performance
29. Stryker Corporation: Drug type Benchmarking
30. Stryker Corporation: Financial Performance
31. Allergan USA, Inc.: Drug type Benchmarking
32. Allergan USA, Inc.: Financial Performance
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Depression Drugs Market share, By Drug type, 2020 & 2028 (%)
10. Global Depression Drugs Market share, by Tricyclic Antidepressants, By Drug type, 2015 - 2028 (USD Million)
11. Global Depression Drugs Market share, by Serotonin-Norepinephrine Inhibitors, By Drug type, 2015 - 2028 (USD Million)
12. Global Depression Drugs Market share, by Atypical Antipsychotics, By Drug type, 2015 - 2028 (USD Million)
13. Global Depression Drugs Market share, by Selective Serotonin Reuptake Inhibitors, By Drug type, 2015 - 2028 (USD Million)
14. Global Depression Drugs Market share, by Benzodiazepines, By Drug type, 2015 - 2028 (USD Million)
15. Global Depression Drugs Market share, by Tetracyclic Antidepressants, By Drug type, 2015 - 2028 (USD Million)
16. Global Depression Drugs Market share, by Monoamine Oxidase Inhibitors, By Drug type, 2015 - 2028 (USD Million)
17. Global Depression Drugs Market share, by Other, By Drug type, 2015 - 2028 (USD Million)
18. Global Depression Drugs Market share, By Disease Type, 2020 & 2028 (%)
19. Global Depression Drugs Market share, by Major Depressive Disorder, By Disease Type, 2015 - 2028 (USD Million)
20. Global Depression Drugs Market share, by Schizophrenia, By Disease Type, 2015 - 2028 (USD Million)
21. Global Depression Drugs Market share, by Bipolar I Disorder, By Disease Type, 2015 - 2028 (USD Million)
22. Global Depression Drugs Market share, by Selective Serotonin Reuptake Inhibitor Induced Disorder, By Disease Type, 2015 - 2028 (USD Million)
23. Global Depression Drugs Market share, by Others, By Disease Type, 2015 - 2028 (USD Million)
24. Global Depression Drugs Market share, By Distribution channel, 2020 & 2028 (%)
25. Global Depression Drugs Market share, by Hospital pharmacies, By Distribution channel, 2015 - 2028 (USD Million)
26. Global Depression Drugs Market share, by Retail pharmacies, By Distribution channel, 2015 - 2028 (USD Million)
27. Global Depression Drugs Market share, by Online pharmacies, By Distribution channel, 2015 - 2028 (USD Million)
28. Global Depression Drugs Market share, by Clinics, By Distribution channel, 2015 - 2028 (USD Million)
29. Global Depression Drugs Market share, by Research centres, By Distribution channel, 2015 - 2028 (USD Million)
30. Global Depression Drugs Market share, by Other, By Distribution channel, 2015 - 2028 (USD Million)
31. Global Depression Drugs Market share, by Region, 2020 & 2028 (%)
32. Global Depression Drugs Market share, by Region, 2015 - 2028(USD Million)
33. North America Depression Drugs Market, 2015 - 2028(USD Million)
34. North America Depression Drugs Market share, by Countries, 2020 & 2028 (%)
35. U.S. Depression Drugs Market, 2015 - 2028(USD Million)
36. Canada Depression Drugs Market, 2015 - 2028(USD Million)
37. Mexico Depression Drugs Market, 2015 - 2028(USD Million)
38. Europe Depression Drugs Market, 2015 - 2028(USD Million)
39. Europe Depression Drugs Market share, by Countries, 2020 & 2028 (%)
40. Spain Depression Drugs Market, 2015 - 2028(USD Million)
41. UK Depression Drugs Market, 2015 - 2028(USD Million)
42. Italy Depression Drugs Market, 2015 - 2028(USD Million)
43. Germany Depression Drugs Market, 2015 - 2028(USD Million)
44. France Depression Drugs Market, 2015 - 2028(USD Million)
45. Rest of Europe Depression Drugs Market, 2015 - 2028(USD Million)
46. Asia-Pacific Depression Drugs Market, 2015 - 2028(USD Million)
47. Asia-Pacific Depression Drugs Market share, by Countries, 2020 & 2028 (%)
48. China Depression Drugs Market, 2015 - 2028(USD Million)
49. India Depression Drugs Market, 2015 - 2028(USD Million)
50. Australia Depression Drugs Market, 2015 - 2028(USD Million)
51. Japan Depression Drugs Market, 2015 - 2028(USD Million)
52. Rest of Asia-Pacific Depression Drugs Market, 2015 - 2028(USD Million)
53. Middle East & Africa Depression Drugs Market, 2015 - 2028(USD Million)
54. Middle East & Africa Depression Drugs Market share, by Countries, 2020 & 2028 (%)
55. GCC Depression Drugs Market, 2015 - 2028(USD Million)
56. South Africa Depression Drugs Market, 2015 - 2028(USD Million)
57. Rest Of Middle East & Africa Depression Drugs Market, 2015 - 2028(USD Million)
58. South America Depression Drugs Market, 2015 - 2028(USD Million)
59. Brazil Depression Drugs Market, 2015 - 2028(USD Million)
60. Mexico Depression Drugs Market, 2015 - 2028(USD Million)
61. Argentina Depression Drugs Market, 2015 - 2028(USD Million)
62. Rest Of South America Depression Drugs Market, 2015 - 2028(USD Million)
The Leading Key Players in Global Global Depression Drugs Market
